Company Description

Developing best-in-class ultra-long-acting medicines for chronic viral infections and CNS disorders, where better adherence and compliance can dramatically improve patient outcomes. Exavir Therapeutics is a preclinical stage biotechnology company dedicated to eliminating HIV and other viral infections.